Simonsen et al used the Norwegian and Danish national health registries and found an increased risk of NAION development with semaglutide initiation (HR = 2.81)
This hormone stimulates insulin release from the pancreas, suppresses glucagon secretion, slows gastric emptying, and acts on the brain to reduce appetite
Anyone starting a new medication should ask their pharmacist about photosensitivity risks
injections (between 15:00 and 17:00) of 100 nmol kg 1 MK-801, 10 nmol kg 1 semaglutide, 100 nmol kg 1 GLP-1MK-801 or vehicle, with concomitant measurements of body weight and food intake
Gentle stretching exercises, particularly before bedtime and before physical activity, can reduce the frequency and severity of muscle cramps
Among the most promising treatments we provide are GLP-1 medications, a specialized class of medications known as glucagon-like peptide-1 receptor agonists